📰 Potential Therapy News
Potential Therapy News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Potential Therapy. Real-time updates on events, politics, business and more.
May 9, 2023
/PRNewswire/ -- Palatin Technologies, Inc. (NYSE American: PTN), a biopharmaceutical company developing first-in-class medicines based on molecules that...
October 24, 2022
Preclinical data shows efficacy in animal models of ulcerative colitisHuman pharmacokinetic data show oral formulation releases PL8177 in colonCRA...
October 24, 2022
/PRNewswire/ -- Palatin Technologies, Inc. (NYSE American: PTN), a biopharmaceutical company developing first-in-class medicines based on molecules that...
October 24, 2022
/PRNewswire/ -- Palatin Technologies, Inc. (NYSE American: PTN), a biopharmaceutical company developing first-in-class medicines based on molecules that...
June 30, 2022
Igraine Plc - Unaudited Financial Statements to 31 December 2021 PR Newswire London, June 30 Igraine plc AQSE: KING ("Igraine" or "the company") Unaudited Financial
December 22, 2021
Igraine Plc - Audited Results to 31 December 2020 PR Newswire London, December 22 IGRAINE PLC AQSE: KING ("Igraine" or the "Company") Audited Final Results
January 20, 2021
Veru Announces Nature Medicine Publication Demonstrating that Enobosarm, an Androgen Receptor Targeted Agent, Inhibits Hormone Receptor Positive Metastatic Breast Cancer that has Become Resistant to Estrogen Receptor Targeted Endocrine and CDK4/6 Inhibitor Therapies January 19, 2021 08:30 ET | Source: Veru Inc. Veru Inc. Miami, Florida, UNITED STATES --International Study Establishes the Role of Androgen Receptor as a Tumor Suppressor in ER+ Advanced...